Directorate General for Medical Devices, Pharmaceutical Services and Safety in Healthcare (La Direzione generale dei dispositivi medici, del servizio farmaceutico e della sicurezza delle cure svolge)
The Directorate General for Medicines and Medical Devices (DG-MED) is the name of the government agency in Italy that is in charge of monitoring and regulating pharmaceuticals and medical equipment. It ensures the safety, efficacy, and quality of medical supplies and drugs in Italy. The DG-MED is also responsible for overseeing the registration, monitoring, and regulation of pharmaceutical products, including both prescription and over-the-counter medications.
Additionally, it is in charge of implantable and diagnostic medical device registration, conformity testing, and post-market supervision. The DG-MED gives instructions for manufacturers to ensure that Italian and EU regulations are being obeyed.
Italy stands as a well-established market for medical equipment, ranking as the fourth largest in Europe after Germany, France, and the UK. The sector comprises approximately 4,500 companies, with 42% functioning as distributors, 53% as producers, and 5% as service providers, collectively employing over 118,000 individuals. In 2021, the medical device market, encompassing dental and optical devices, reached a valuation of $11.8 billion, with imports contributing $7.8 billion.
Notably, more than 75% of medical device purchases occur in public hospitals, while the private sector accounts for the remaining 25%. Anticipated market growth may face constraints due to economic deceleration and cost-containment measures, such as the “payback” system, requiring companies to cover government spending surpassing budget limits.
Class I, IIa, IIb III
30 – 45 Days
No fees
5 Years
DoC, labelling and IFUs must be in Italian
In 2024, the Medical Devices market in Italy is anticipated to achieve a revenue of US$12.85 billion, with the largest market segment expected to reach US$1.75 billion, contributing to an overall market volume of US$182.00 billion. Looking forward, a steady annual growth rate of 3.79% (CAGR 2024-2028) is projected, leading to a market volume of US$14.91 billion by 2028.
The United States is forecasted to dominate the global Medical Devices market, generating the highest revenue of US$182.00 billion in 2024. Italy’s surge in demand for cutting-edge technologies and a heightened emphasis on telemedicine solutions is contributing to the growth of its medical device market.
In Italy, medical device registration involves no set fees, but requires manufacturers outside the EU to appoint an Authorized Representative. While the full transition to the new Medical Device Regulation (MDR) occurred in May 2022, some aspects still utilize the national database due to ongoing system updates.
Registration timelines vary depending on device class, and associated costs may include notified body fees, translations, and consultancy services. For the latest regulations and specific device requirements, always consult the Ministry of Health website or seek professional guidance.
Before placing a medical device into the market.
Contact us for free consultation: info@omcmedical.co.uk
Our team will be happy to respond your queries. Contact us directly with your questions or for scheduling FREE consultation and we’ll be in touch as soon as possible.
Our team will be happy to respond your queries. Contact us directly with your questions or for scheduling FREE consultation and we’ll be in touch as soon as possible.
Our team will be happy to respond your queries. Contact us directly with your questions or for scheduling FREE consultation and we’ll be in touch as soon as possible.
To launch a medical device in a country, medical devices must comply with the local country’s regulatory requirements. Let us be your trusted partner in bringing your medical devices to the Global market. Contact us today to learn more about how we can assist you in every step of the way.
This will close in 0 seconds